Detalhe da pesquisa
1.
Randomized double-blind, placebo-controlled multicenter phase III study of prevention of irinotecan-induced diarrhea by a probiotic mixture containing Bifidobacterium BB-12®Lactobacillus rhamnosus LGG® in colorectal cancer patients.
Front Oncol;
13: 1168654, 2023.
Artigo
em Inglês
| MEDLINE
| ID: mdl-37601667